Biomaterials for Drug Delivery and Cancer Therapy

Dear Colleagues,

This Special Issue, titled "Biomaterials for Drug Delivery and Cancer Therapy", comprises a comprehensive collection of articles that explore the latest advancements concerning the biomaterials used for targeted drug delivery and cancer treatment. This Issue aims to provide readers with a deeper understanding of the innovative approaches being developed to improve the efficacy and safety of cancer therapies.

Cancer remains one of the most significant health challenges worldwide, with millions of new cases diagnosed each year. Despite significant progress in cancer research, the development of more effective and less toxic treatments is still an urgent need. Biomaterials play a crucial role in addressing this challenge by offering novel strategies for targeted drug delivery and localized therapy, which can minimize systemic side effects and enhance treatment outcomes.

As we continue to unravel the complexities of cancer biology and strive for more personalized and effective treatments, the articles in this Special Issue serve as a testament to the power of interdisciplinary collaboration and innovation in the fight against cancer. We hope that this collection will inspire further research and developments in the field of biomaterials for drug delivery and cancer therapy, ultimately contributing to improved patient outcomes and quality of life. Areas of interest include (but not limited to) the following:

1. New techniques/functional biomaterials for cancer diagnosis and therapeutics;
2. New applications and advantages of functional biomaterials;
3. Mechanisms/insights/reviews of different biomaterials regarding cancer treatment to guide future studies;
4. Negative results with detailed methods/rationales/discussions on cancer therapy;
5. Biomaterials for targeted delivery.

Dr. Wen Yang
Dr. Chao Qi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Functional Biomaterials is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.